臨床薬理の進歩 No.43

36/233

ytiliytiliaiiiiibiiiiibaVbaVytiliytilibaVbaVytiliytilibaVbaVytiliytilibaVbaVytiliytilibaVbaVMMMMMMChemoChemo + GSK2830371 1Chemo + GSK2830371 20Chemo + GSK2830371 40図5　In vitroでのヒトALL細胞株の細胞生存アッセイa B細胞性ALL細胞株（REH細胞）、b B細胞性ALL細胞株（RCH細胞）を用いた結果。221.51.00.5-70.01.51.00.5-100.01.51.00.50.0-71.51.00.50.0-101.51.00.50.0-86-MP,[M]AraC,[M]-6MAF,[M]-5-4-9-8VCR,[M]-7-6-5-4-3-9-8-7DNR,[M]-6-7-6-5-41.51.00.5-7-6MAF,[M]0.01.51.00.5-11-10-90.01.51.00.50.0-7-61.51.00.50.0-9-81.51.00.50.0-9-8-7AraC,[M]VCR,[M]6-MP,[M]DNR,[M]-5-4-8-7-5-4-7-6-5-4ChemoChemo + GSK2830371 10Chemo + GSK2830371 20Chemo + GSK2830371 30REHRCH